Our findings demonstrate that FTO suppresses glioma proliferation and cell cycle progression by regulating the stability of Epiregulin (EREG) mRNA and subsequently inactivating the PI3K/Akt signaling pathway, thereby establishing its role as a key tumor suppressor in glioma. The gene discussed is EREG; the disease is central nervous system cancer.